» Articles » PMID: 20372057

Revised Genetic Requirements for the Decatenation G2 Checkpoint: the Role of ATM

Overview
Journal Cell Cycle
Specialty Cell Biology
Date 2010 Apr 8
PMID 20372057
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The decatenation G2 checkpoint is proposed to delay cellular progression from G2 into mitosis when intertwined daughter chromatids are insufficiently decatenated. Previous studies indicated that the ATM- and Rad3-related (ATR) checkpoint kinase, but not the ataxia telangiectasia-mutated (ATM) kinase, was required for decatenation G2 checkpoint function. Here, we show that the method used to quantify decatenation G2 checkpoint function can influence the identification of genetic requirements for the checkpoint. Normal human diploid fibroblast (NHDF) lines responded to the topoisomerase II (topo II) catalytic inhibitor ICRF-193 with a stringent G2 arrest and a reduction in the mitotic index. While siRNA-mediated depletion of ATR and CHEK1 increased the mitotic index in ICRF-193 treated NHDF lines, depletion of these proteins did not affect the mitotic entry rate, indicating that the decatenation G2 checkpoint was functional. These results suggest that ATR and CHEK1 are not required for the decatenation G2 checkpoint, but may influence mitotic exit after inhibition of topo II. A re-evaluation of ataxia telangiectasia (AT) cell lines using the mitotic entry assay indicated that ATM was required for the decatenation G2 checkpoint. Three NHDF cell lines responded to ICRF-193 with a mean 98% inhibition of the mitotic entry rate. Examination of the mitotic entry rates in AT fibroblasts upon treatment with ICRF-193 revealed a significantly attenuated decatenation G2 checkpoint response, with a mean 59% inhibition of the mitotic entry rate. In addition, a normal lymphoblastoid line exhibited a 95% inhibition of the mitotic entry rate after incubation with ICRF-193, whereas two AT lymphoblastoid lines displayed only 36% and 20% inhibition of the mitotic entry rate. Stable depletion of ATM in normal human fibroblasts with short hairpin RNA also attenuated decatenation G2 checkpoint function by an average of 40%. Western immunoblot analysis demonstrated that treatment with ICRF-193 induced ATM autophosphorylation and ATM-dependent phosphorylation of Ser15-p53 and Thr68 in Chk2, but no appreciable phosphorylation of Ser139-H2AX or Ser345-Chk1. The results suggest that inhibition of topo II induces ATM to phosphorylate selected targets that contribute to a G2 arrest independently of DNA damage.

Citing Articles

AAV vector transduction restriction and attenuated toxicity in hESCs via a rationally designed inverted terminal repeat.

Song L, Hasegawa T, Brown N, Bower J, Samulski R, Hirsch M Nucleic Acids Res. 2025; 53(3).

PMID: 39868534 PMC: 11760972. DOI: 10.1093/nar/gkaf013.


Cell cycle responses to Topoisomerase II inhibition: Molecular mechanisms and clinical implications.

Soliman T, Keifenheim D, Parker P, Clarke D J Cell Biol. 2023; 222(12).

PMID: 37955972 PMC: 10641588. DOI: 10.1083/jcb.202209125.


Dysregulated G2 phase checkpoint recovery pathway reduces DNA repair efficiency and increases chromosomal instability in a wide range of tumours.

Fernando M, Duijf P, Proctor M, Stevenson A, Ehmann A, Vora S Oncogenesis. 2021; 10(5):41.

PMID: 33993200 PMC: 8124070. DOI: 10.1038/s41389-021-00329-8.


Copper Complexes as Anticancer Agents Targeting Topoisomerases I and II.

Molinaro C, Martoriati A, Pelinski L, Cailliau K Cancers (Basel). 2020; 12(10).

PMID: 33027952 PMC: 7601307. DOI: 10.3390/cancers12102863.


Cell Cycle-Dependent Control and Roles of DNA Topoisomerase II.

Lee J, Berger J Genes (Basel). 2019; 10(11).

PMID: 31671531 PMC: 6896119. DOI: 10.3390/genes10110859.


References
1.
Anantha R, Sokolova E, Borowiec J . RPA phosphorylation facilitates mitotic exit in response to mitotic DNA damage. Proc Natl Acad Sci U S A. 2008; 105(35):12903-8. PMC: 2529075. DOI: 10.1073/pnas.0803001105. View

2.
Chen B, Simpson D, Zhou Y, Mitra A, Mitchell D, Cordeiro-Stone M . Human papilloma virus type16 E6 deregulates CHK1 and sensitizes human fibroblasts to environmental carcinogens independently of its effect on p53. Cell Cycle. 2009; 8(11):1775-87. PMC: 4471864. DOI: 10.4161/cc.8.11.8724. View

3.
Li H, Wang Y, Liu X . Plk1-dependent phosphorylation regulates functions of DNA topoisomerase IIalpha in cell cycle progression. J Biol Chem. 2008; 283(10):6209-21. DOI: 10.1074/jbc.M709007200. View

4.
Hartwell L . Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell. 1992; 71(4):543-6. DOI: 10.1016/0092-8674(92)90586-2. View

5.
Nakagawa T, Hayashita Y, Maeno K, Masuda A, Sugito N, Osada H . Identification of decatenation G2 checkpoint impairment independently of DNA damage G2 checkpoint in human lung cancer cell lines. Cancer Res. 2004; 64(14):4826-32. DOI: 10.1158/0008-5472.CAN-04-0871. View